Velvio Gmbh
Impressum/Imprint: https://velvio.com/imprint.html Velvio develops new medicines to restore organ repair functions for treatment in Neurodegeneration and Pulmonary Fibrosis, first in Orphan diseases Amyotrophic Lateral Sclerosis (ALS) and Idiopathic pulmonary Fibrosis (IPF). Furthermore Velvio targets to enhance clinical responses of solid tumors to Immune-Oncology treatment concepts. Based on our highly promising pre-clinical pipeline, we are ready to go “first in man” in ALS, in IPF we are about to finish preclinical in vivo drug development.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Velvio Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Velvio Gmbh
1 distinct titles indexed · top 1 shown.
- 1chief medical officer
Sign up to unlock all 1 contacts at Velvio Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Velvio Gmbh
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.